Graft coronary vasculopathy in cardiac transplantation - Evaluation of risk factors by multivariate analysis

European Journal of Cardio-thoracic Surgery

Volumn 10, Issue 1, 1996, Pages 1-5

  Wahlers, T ^a   Fieguth, H G ^a   Jurmann, M ^a   Albes, J ^a   Hausen, B ^a   Demertzis, S ^a   Schafers H J ^a   Oppelt, P ^a   Mugge A ^a   Borst, H G ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Cardiac transplantation evaluation; Coronary vasculopathy; Risk factors

Indexed keywords

ADULT; ARTICLE; CORONARY ARTERY DISEASE; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATION; RETROSPECTIVE STUDY; RISK FACTOR;

ADULT; CORONARY DISEASE; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0029689579     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1010-7940(96)80258-2     Document Type: Article

References (38)

1. Billingham ME (1987) Cardiac transplant atherosclerosis. Transplant Proc 19:(suppl 5):19-22
2. Billingham ME (1989) Graft coronary disease: the lesions and the patients Transplant Proc 4:3665-3668
3. Billingham ME, Cary NB, Hammond ME, Kemnitz J, Marboe C, McCallister HA, Snovar DC, Winters GL, Zerbe A (1990) A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. J Heart Transplant 9:587-593
4. Cremer J, Wahlers T, Fieguth H-G, Schäfers H-J, Albes J, Kemnitz J, Haverich A (1991) Abstoßungsprophylaxe und Therapie mit OKT3 versus ATG. Z Transplantationsmed 3:39-44
5. English TA, Wallwork J, Verney GI, Appleton D, Davies H (1988) Coronary occlusive disease in the transplanted heart (Abstract). J Heart Transplant 7:88
6. Fieguth H-G, Heublein B, Wahlers T, Schäfers H-J, Stangel W, Kemnitz J, Haverich A (1991) Impact of HLA-compatibility on rejection sequence, graft atherosclerosis and survival rate after orthotopic heart transplantation. Transplant Proc 23:1137-1138
7. Foegh ML, Khirabadi BS, Nakanishi T, Vargas R, Ramwell PW (1987) Estradiol protects against experimental cardiac transplant atherosclerosis. Transplant Proc 19 (suppl 5):90-93
8. Foegh ML, Khirabadi BS, Chambers E, Amamoo S, Ramwell PW (1989) Inhibition of coronary artery transplant atherosclerosis in rabbits with angiopeptin, an octapeptide. Atherosclerosis 78:229-234
9. Gao SZ, Schroeder JS, Alderman EL, Hunt SA, Valantine HA, Wiederhold V, Stinson EB (1989) Prevalence of accelerated coronary artery disease in heart transplant survivors. Circulation 80(suppl III):III-100-105
10. Gao SZ, Alderman EL, Schroeder JS, Hunt SH, Wiederhold V, Stinson EB (1990) Progressive coronary luminal narrowing after cardiac transplantation. Circulation 82 (suppl IV): IV-269-275
11. Grace AA, Barradas MA, Mikhailidis DP, Jeremy JY, Moorhead JF, Sweny P, Dandona P (1987) Cyclosporin A enhances platelet aggregation. Kidney Int 32:889-895
12. Hastillo A, Cowley MJ, Vetrovec G, Wolfgang TC, Lower RR, Hess ML (1985) Serial coronary angioplasty for atherosclerosis following heart transplantation. J Heart Transplant 4:192-195
13. Hess ML, Hastillo A, Mohanakumar T, Cowley MJ, Vetrovac G, Szentpetery S, Wolfgang TC, Lower RR (1983) Accelerated atherosclerosis in cardiac transplantation: role of cytotoxic B-cell antibodies and hyperlipidemia. Circulation 68 (suppl II): II-94-101
14. Kemnitz J, Cohnert T, Schäfers H-J, Helmke M, Wahlers T, Herrmann G, Schmidt R-M, Haverich A (1987) A classification of cardiac allograft rejection. Am J Surg Pathol 11:503-515
15. Kriett JM, Kaye MP (1991) The registry of the International Society for Heart and Lung Transplantation: 8th official report-1991. J Heart Lung Transplant 10:491-498
16. Libby P, Salomon RN, Payne DD, Schoen FJ, Pober JS (1989) Functions of vascular wall cells related to development of transplantation-associated coronary arteriosclerosis. Transplant Proc 21:3677-3684
17. Loebe M, Schüler S, Zais O, Warnecke H, Fleck E, Hetzer R (1990) Role of cytomegalovirus infection in the development of coronary artery disease in the transplanted heart. J Heart Transplant 9:707-711
18. Majesky MW, Schwartz SM, Clowes MM, Clowes AW (1987) Heparin regulates smooth muscle S-phase entry in the injury red rat carotid artery. Circ Res 61:296-301
19. McDonald K, Rector TS, Braunlin EA, Kubo SH, Olivari MT (1989) Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection. Am J Cardiol 64:359-362
20. Narrod J, Kormos R, Armitage J, Hardesty R, Ladowski J, Griffith B (1989) Acute rejection and coronary artery disease in long-term survivors of heart transplantation. J Heart Transplant 8:418-421
21. Nath A, Vetrovec GW, Disciacio G, Thompson JA, Taylor DO, Hastillo A, Cowley JM, Hess ML (1990) Coronary angiographic findings in heart transplant patients with clinical suspension of coronary artery disease. Eur Heart J 8:(suppl):251-254
22. Nilsson J, Sjölund M, Palmberg L, Von Euler AM, Jonzon B, Thyberg J (1985) The calcium antagonist nifedipine inhibits arterial smooth muscle cell proliferation. Atherosclerosis 58:109-114
23. O'Neill BJ, Pflugfelder PW, Singh NR, Menkis AH, McKenzie FN, Kostuk WJ (1989) Frequency of angiographic detection and quantitative assessment of coronary arterial disease one and three years after cardiac transplantation. Am J Cardiol 63:1221-1226
24. Olivari MT, Homanns DC, Wilson RF, Kubo SH, Ring WS (1989) Coronary artery disease in cardiac transplant patients receiving triple drug therapy. Circulation 80 (suppl III):III-111-115
25. Petrossian GA, Nichols AB, Marboe CC, Sciacca R, Rose EA, Smith CR, Cannon PJ, Reemtsma K, Powers, ER (1989) Relation between survival and development of coronary artery disease and anti-HLA antibodies after cardiac transplantation. Circulation 80 (suppl III):III-122-125
26. Ross R (1986) The pathogenesis of atherosclerosis: an update. N Engl J Med 314:488-500
27. Salomon RN, Hughes CCW, Schoen FJ, Payne DD, Pober JS, Libby P (1991) Human coronary transplantation-associated arteriosclerosis. Evidence for a chronic immune reaction to activated graft endothelial cells. Am J Pathol 138:791-798
28. Scheldt WV, Uhl W, Ziegler U, Kemkes BM, Erdmann E (1990) Coronary angioplasties after heart transplantation. Eur Heart J 11:(suppl):322
29. Schüler S, Warnecke H, Bossaller C, Strasser R, Fleck E, Hetzer R (1990) Long-term graft function and incidence of coronary artery disease after orthotopic heart transplantation. Eur Heart J II:(suppl):186-188
30. St Goar FG, Pinto FJ, Alderman EL, Valantine HA, Schroeder JS, Gao SZ, Stinson EB, Popp RL (1992) Intracoronary ultrasound in cardiac transplant recipients. Circulation 85:979-987
31. Stovin PGI, Sharples L, Hutter JA, Wallwork J, English TAH (1991) Some prognostic factors for the development of transplant-related coronary artery disease in human cardiac allografts. J Heart Lung Transplant 10:38-44
32. Uretsky BF, Murali S, Reddy PS, Rabin B, Lee A, Griffith BP, Hardesty RL, Trento A, Bahnson HT (1987) Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone. Circulation 76:827-834
33. Uys CJ, Rose AG (1984) Pathologic findings in long-term cardiac transplants. Arch Pathol Lab Med 108:112-116
34. Wahlers T, Frimpong-Boateng K, Schäfers H-J, Fieguth H-G, Jurmann M, Herrmann G, Kemnitz J, Haverich A (1987) Abstoßungsbehandlung nach Herztransplantation mit oraler Steroidmedikation. Dtsch Med Wochenschr 112:1816-1818
35. Wahlers T, Herrmann G, Jurmann M, Fieguth H-G, Cremer J, Haverich A (1989) A high incidence of early acute rejection does not correlate with the number of late rejections following heart transplantation. Transplant Proc 21:2531-2532
36. Wahlers T, Cremer J, Fieguth H-G, Jurmann M, Herrmann G, Schäfers H-J, Wonigeit K, Borst HG (1989) Adjusted triple drug immunosuppression and kidney function following heart transplantation. Transplant Proc 21:2492-2493
37. Wahlers T, Heublein B, Cremer J, Fieguth H-G, Albes J, Schäfers H-J, Haverich A, Borst HG (1990) Treatment of rejection after heart transplantation: What dosage of pulsed steroids is necessary? J Heart Transplant 5:568-574
38. Zusman DR, Stinson EB, Oyer PE, Baldwin JC, Jamieson SW, McGregor CG, Hunt SA, Schroeder JS (1985) Determinants of accelerated graft atherosclerosis (AGAS) in conventional and cyclosporine-treated heart transplant recipients (abstract). J Heart Transplant 4:587